...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Halted

 That's a bummer - I thought we might get some good news.

Perhaps one of these days/months/years?

Share
New Message
Please login to post a reply